Bead compacts. II. Evaluation of rapidly disintegrating nonsegregating compressed bead formulations

Drug Development and Industrial Pharmacy

Volumn 25, Issue 5, 1999, Pages 635-642

  Altaf, Syed A ^a,b   Hoag, Stephen W ^a,c   Ayres, James W ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b GILEAD SCIENCES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYL CELLULOSE; MACROGOL; PARACETAMOL; SEBACIC ACID DIBUTYL ESTER;

ARTICLE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; PARTICLE SIZE; PRESSURE; SUSTAINED RELEASE PREPARATION; TECHNIQUE;

CHEMISTRY, PHARMACEUTICAL; PARTICLE SIZE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 0032941909     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102219     Document Type: Article

References (26)

1. R. Bodmeier, Eur. J. Pharm. Biopharm., 43, 1-8 (1997).
2. M. Celik, in Multiparticulate Oral Drug Delivery, Marcel Dekker, New York, 1994, pp. 181-215.
3. G. Ragnarsson, A. Sandberg, U. E. Jonsson, and J. Sjögren, Drug Dev. Ind. Pharm., 13(9-11), 1495-1509 (1987).
4. M. E. Aulton, A. M. Dyer, and K. A. Khan, Drug Dev. Ind. Pharm., 20(20), 3069-3104 (1994).
5. M. Celik and L. Maganti, Drug Dev. Ind. Pharm., 20(20), 3151-3173 (1994).
6. S. R. Béchard and J. C. Leroux, Drug Dev. Ind. Pharm., 18(18), 1927-1944 (1992).
7. R. K. Chang and E. M. Rudnic, Int. J. Pharm., 70, 261-270 (1991).
8. Colorcon, Coating for Chlorpheniramine Maleate Non-Pareils Compressed into Tablets, Technical Data, PT-38, Author, West Point, PA, 1992.
9. M. Celik and L. Maganti, Int. J. Pharm., 103, 55-67 (1994).
10. M. Juslin, L. Turakka, and P. Puumalainen, Pharm. Ind., 42, 829-832 (1980).
11. W. Prapaitrakul and C. W. Whitworth, Drug Dev. Ind. Pharm., 15(12), 2049-2053 (1989).
12. R. Ruiz, A. Sakr, and O. L. Sprockel, Drug Dev. Ind. Pharm., 16(11), 1829-1842 (1990).
13. H. A. M. Sayed and J. C. Price, Drug Dev. Ind. Pharm., 12(4), 577-587 (1986).
14. J. B. Scwhartz, N. H. Nguyen, and R. L. Schnaare, Drug Dev. Ind. Pharm., 20(20), 3105-3129 (1994).
15. D. L. Mount and J. B. Scwhartz, Drug Dev. Ind. Pharm., 22(7), 609-621 (1996).
16. J. J. Torrado and L. L. Augsburger, Int. J. Pharm., 106, 149-155 (1994).
17. C. M. McTaggart, J. A. Ganley, A. Sickmueller, and S. E. Walker, Int. J. Pharm., 19, 139-148 (1984).
18. C. Chemtob, J. C. Chaumeil, and M. N'Dongo, Int. J. Pharm., 29, 83-92 (1986).
19. A. A. Badwan, A. Abumalooh, E. Sallam, A. Abukalaf, and O. Jawan, Drug Dev. Ind. Pharm., 11(2&3), 239-256 (1985).
20. I. Jalsenjak, J. R. Nixon, R. Senjkovic, and I. Svtivic, J. Pharm. Pharmacol., 32, 678-680 (1980).
21. Z. T. Chowhan, Pharm. Technol., 19(5), 56-70 (1995).
22. Z. T. Chowhan, Pharm. Technol., 19(6), 80-94 (1995).
23. S. A. Altaf, S. W. Hoag, and J. W. Ayres, Drug Dev. Ind. Pharm., 24(8), 737-746 (1998).
24. J. W. Connie and H. R. Hadley, Drug Cosmetic Indus., 106, 38-41 (1970).
25. P. L. Madan, L. A. Luzzi, and J. C. Price, J. Pharm. Sci., 63(2), 280-284 (1974).
26. FMC Corporation, FMC Problem Solver and Reference Manual Binder, Author, Philadelphia, 1984.